Form 4: Astera Labs CFO Michael Tate Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
Astera Labs' Chief Financial Officer, Michael Tate, acquired 694 shares of common stock through the company's Employee Stock Purchase Plan.
Summary
- Michael Tate, the Chief Financial Officer of Astera Labs, Inc., acquired 694 shares of common stock on November 14, 2024.
- The shares were purchased at a price of $30.6 per share.
- This transaction was part of the company's 2024 Employee Stock Purchase Plan.
- Following the transaction, Mr. Tate directly owns 293,822 shares of common stock.
- Mr. Tate also indirectly owns 1,762,888 shares through the Tate Trust, where he is a trustee.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction, indicating a positive but not extraordinary sentiment. The CFO's participation in the employee stock purchase plan is a positive sign.
Positives
- The purchase demonstrates the CFO's confidence in the company's future.
- The transaction was part of the company's employee stock purchase plan, which is a positive benefit for employees.
Industry Context
This is a routine transaction for a company with an employee stock purchase plan, and it is common for executives to participate in such plans.
Comparison to Industry Standards
- Employee stock purchase plans are a common practice among publicly traded companies, particularly in the technology sector, to incentivize and reward employees.
- The level of participation by executives in these plans is generally seen as a positive sign of their confidence in the company's prospects.
- Comparable companies in the semiconductor industry, such as Marvell Technology and Broadcom, also offer similar employee stock purchase programs.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it demonstrates management's confidence in the company.
- Employees benefit from the employee stock purchase plan.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date of the share acquisition by Michael Tate. |
| 11/18/2024 | Date of the signature on the Form 4 filing. |
Keywords
Astera Labs, Michael Tate, Employee Stock Purchase Plan, Share Acquisition, CFO, Stock Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.